GB9026229D0 - Tolerogenic conjugates for suppressing immune responses - Google Patents
Tolerogenic conjugates for suppressing immune responsesInfo
- Publication number
- GB9026229D0 GB9026229D0 GB909026229A GB9026229A GB9026229D0 GB 9026229 D0 GB9026229 D0 GB 9026229D0 GB 909026229 A GB909026229 A GB 909026229A GB 9026229 A GB9026229 A GB 9026229A GB 9026229 D0 GB9026229 D0 GB 9026229D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- immune responses
- suppressing immune
- tolerogenic
- conjugates
- tolerogenic conjugates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000028993 immune response Effects 0.000 title 1
- 230000003614 tolerogenic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44426389A | 1989-12-01 | 1989-12-01 | |
GB898927373A GB8927373D0 (en) | 1989-12-04 | 1989-12-04 | Tolerogenic conjugates for suppressing immune responses |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9026229D0 true GB9026229D0 (en) | 1991-01-16 |
GB2238959A GB2238959A (en) | 1991-06-19 |
GB2238959B GB2238959B (en) | 1993-10-20 |
Family
ID=26296306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9026229A Expired - Fee Related GB2238959B (en) | 1989-12-01 | 1990-12-03 | Antigen and conjugates thereof for suppressing immune response |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2238959B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6093699A (en) * | 1987-07-09 | 2000-07-25 | The University Of Manitoba | Method for gene therapy involving suppression of an immune response |
AU8001694A (en) * | 1993-11-03 | 1995-05-23 | University Of Manitoba | Cell control and suppression |
-
1990
- 1990-12-03 GB GB9026229A patent/GB2238959B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB2238959A (en) | 1991-06-19 |
GB2238959B (en) | 1993-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0382796A4 (en) | Method for the preparation of antibody-fragment conjugates | |
GB8903313D0 (en) | Conjugates | |
ZA879473B (en) | Immunoglubolin conjugates | |
DE69026272D1 (en) | Rheometer | |
IL92230A0 (en) | Antibody-drug conjugates | |
GB8908250D0 (en) | Formulations | |
GB8921470D0 (en) | Vaccines | |
EP0468714A3 (en) | Peptide-polysaccharide-protein conjugate vaccines | |
EP0504136A4 (en) | Tolerogenic immunoglobulin-protein conjugates | |
HU905458D0 (en) | Inflammable preparation | |
GB2203154B (en) | Immunoglobulin conjugates | |
GB8919661D0 (en) | Superoxide dismutase-catalase conjugates | |
AP9000174A0 (en) | Antiparasitical formulations | |
GB9026229D0 (en) | Tolerogenic conjugates for suppressing immune responses | |
ZA89524B (en) | Antibody conjugates | |
GB8927373D0 (en) | Tolerogenic conjugates for suppressing immune responses | |
GB8912496D0 (en) | Vaccines | |
IL92583A0 (en) | Tolerogenic immunoglobulin-protein conjugates | |
AU5090290A (en) | Tolerogenic immunoglobulin-protein conjugates | |
NZ238953A (en) | Antibody-superantigen conjugates | |
IE893616L (en) | Antibody-drug conjugates | |
EP0453452A4 (en) | Vaccine | |
ZA907863B (en) | Vaccine conjugate | |
IE883489L (en) | Drug-monoclonalantibody conjugates | |
GB9017729D0 (en) | Conjugates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19961203 |